73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Moderate delays safe in treating colon cancer

Moderate delays safe in treating colon cancer

by Paul Mayne,University of Western OntarioSchulich School of Medicine & Dentistry medical resident Dr. Kerollos Wanis, left, assists Drs. David Bottoni and Robert Black with a cancer-resect

Moderate delays safe in treating colon cancer

by Paul Mayne,University of Western OntarioSchulich School of Medicine & Dentistry medical resident Dr. Kerollos Wanis, left, assists Drs. David Bottoni and Robert Black with a cancer-resect
A two-for-one approach to boost melanoma immunotherapy

A two-for-one approach to boost melanoma immunotherapy

by Sanford Burnham Prebys Medical Discovery InstituteCredit: Unsplash/CC0 Public DomainNew research from Sanford Burnham Prebys has helped explain how melanoma evades the immune system and may gu

A two-for-one approach to boost melanoma immunotherapy

by Sanford Burnham Prebys Medical Discovery InstituteCredit: Unsplash/CC0 Public DomainNew research from Sanford Burnham Prebys has helped explain how melanoma evades the immune system and may gu
Specific components of the tumor immune microenvironment may affect responses to BCMA CAR T-cell therapy

Specific components of the tumor immune microenvironment may affect responses to BCMA CAR T-cell therapy

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainPatients with myeloma whose tumor immune microenvironments had a more diverse baseline T-cell repertoire, fewer marker

Specific components of the tumor immune microenvironment may affect responses to BCMA CAR T-cell therapy

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainPatients with myeloma whose tumor immune microenvironments had a more diverse baseline T-cell repertoire, fewer marker
A liquid biopsy test can identify patients who may respond to immune checkpoint blockade

A liquid biopsy test can identify patients who may respond to immune checkpoint blockade

by American Association for Cancer ResearchCredit: CC0 Public DomainA new liquid biopsy test could detect microsatellite instability (MSI) and tumor mutational burden (TMB), indicating that it co

A liquid biopsy test can identify patients who may respond to immune checkpoint blockade

by American Association for Cancer ResearchCredit: CC0 Public DomainA new liquid biopsy test could detect microsatellite instability (MSI) and tumor mutational burden (TMB), indicating that it co
Combined breast and gynecologic surgery: Study says not so fast

Combined breast and gynecologic surgery: Study says not so fast

by Garth Sundem,CU Anschutz Medical CampusSarah Tevis, MD. Credit: University of ColoradoBreast cancer patients and women undergoing cancer-preventive breast surgeries may consider combining the

Combined breast and gynecologic surgery: Study says not so fast

by Garth Sundem,CU Anschutz Medical CampusSarah Tevis, MD. Credit: University of ColoradoBreast cancer patients and women undergoing cancer-preventive breast surgeries may consider combining the
Researchers identify potential biomarker to distinguish two aggressive types of brain tumors in children

Researchers identify potential biomarker to distinguish two aggressive types of brain tumors in children

by Johns Hopkins University School of MedicineSMYD3 overexpression activates the EGFR pathway in CHLA01 cells. (A) Localization of endogenous SMYD3. Representative 60x Z-stack confocal images sho

Researchers identify potential biomarker to distinguish two aggressive types of brain tumors in children

by Johns Hopkins University School of MedicineSMYD3 overexpression activates the EGFR pathway in CHLA01 cells. (A) Localization of endogenous SMYD3. Representative 60x Z-stack confocal images sho
Team discovers secret to making immune cells better cancer killers

Team discovers secret to making immune cells better cancer killers

by University of VirginiaResearchers Lelisa F. Gemta (left) and Timothy Bullock have determined why killer T cells can be so helpless against cancer. Their finding could allow doctors to make the

Team discovers secret to making immune cells better cancer killers

by University of VirginiaResearchers Lelisa F. Gemta (left) and Timothy Bullock have determined why killer T cells can be so helpless against cancer. Their finding could allow doctors to make the
Some cancer patients can find it hard to tell family and friends

Some cancer patients can find it hard to tell family and friends

by Kenya HunterThis combination of 2023 photos shows Kate, Princess of Wales, left, and U.S. Secretary of Defense Lloyd Austin. For some cancer patients, sharing the news can be a difficult decision.

Some cancer patients can find it hard to tell family and friends

by Kenya HunterThis combination of 2023 photos shows Kate, Princess of Wales, left, and U.S. Secretary of Defense Lloyd Austin. For some cancer patients, sharing the news can be a difficult decision.
Researchers ID novel treatment pathway for deadly pancreatic cancers

Researchers ID novel treatment pathway for deadly pancreatic cancers

by Johns Hopkins University School of MedicineThe High Mobility Group A1 (HMGA1) protein functions as a "molecular switch" that "flips on" expression and secretion of a critic

Researchers ID novel treatment pathway for deadly pancreatic cancers

by Johns Hopkins University School of MedicineThe High Mobility Group A1 (HMGA1) protein functions as a "molecular switch" that "flips on" expression and secretion of a critic
'Collateral damage' from normal cell function may cause mutations that play a role in cancer

'Collateral damage' from normal cell function may cause mutations that play a role in cancer

by Wellcome Trust Sanger InstituteSpatial distribution of APOBEC-positive crypts. APOBEC-positive crypts and their surrounding crypts before microdissection with their SBS mutational spectrums. S

'Collateral damage' from normal cell function may cause mutations that play a role in cancer

by Wellcome Trust Sanger InstituteSpatial distribution of APOBEC-positive crypts. APOBEC-positive crypts and their surrounding crypts before microdissection with their SBS mutational spectrums. S
Lost metabolic fitness of CAR NK cells is key mechanism of tumor resistance, study discovers

Lost metabolic fitness of CAR NK cells is key mechanism of tumor resistance, study discovers

byUniversity of Texas M. D. Anderson Cancer CenterCAR-NK cells have a distinct single-cell transcriptome and metabolic profile. Credit:Science Advances(2023). DOI: 10.1126/sciadv.add

Lost metabolic fitness of CAR NK cells is key mechanism of tumor resistance, study discovers

byUniversity of Texas M. D. Anderson Cancer CenterCAR-NK cells have a distinct single-cell transcriptome and metabolic profile. Credit:Science Advances(2023). DOI: 10.1126/sciadv.add
Rare but important gene target found in many tumor types, suggesting new therapy possible

Rare but important gene target found in many tumor types, suggesting new therapy possible

by Georgetown University Medical CenterStephen V. Liu, MD, an associate professor of medicine at Georgetown Lombardi Comprehensive Cancer Center. Credit: Georgetown UniversityA consortium of rese

Rare but important gene target found in many tumor types, suggesting new therapy possible

by Georgetown University Medical CenterStephen V. Liu, MD, an associate professor of medicine at Georgetown Lombardi Comprehensive Cancer Center. Credit: Georgetown UniversityA consortium of rese